Ben Davis

2.3k total citations
33 papers, 1.5k citations indexed

About

Ben Davis is a scholar working on Molecular Biology, Materials Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Ben Davis has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Materials Chemistry and 7 papers in Computational Theory and Mathematics. Recurrent topics in Ben Davis's work include Protein Structure and Dynamics (13 papers), Enzyme Structure and Function (8 papers) and Computational Drug Discovery Methods (7 papers). Ben Davis is often cited by papers focused on Protein Structure and Dynamics (13 papers), Enzyme Structure and Function (8 papers) and Computational Drug Discovery Methods (7 papers). Ben Davis collaborates with scholars based in United Kingdom, United States and Switzerland. Ben Davis's co-authors include Daniel A. Erlanson, Alan R. Fersht, Roderick E. Hubbard, Martin J. Drysdale, I‐Jen Chen, Wolfgang Jahnke, Fareed Aboul‐ela, Mikael Oliveberg, Yee‐Joo Tan and Andrew Potter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Analytical Chemistry.

In The Last Decade

Ben Davis

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Davis United Kingdom 19 1.2k 349 318 149 135 33 1.5k
Irene Luque Spain 27 1.4k 1.2× 302 0.9× 406 1.3× 151 1.0× 82 0.6× 65 2.2k
Jayashree Srinivasan United States 11 1.7k 1.4× 380 1.1× 310 1.0× 225 1.5× 147 1.1× 16 2.2k
Paul E. Morin United States 17 990 0.8× 216 0.6× 160 0.5× 177 1.2× 129 1.0× 25 1.5k
Andrew A. Bogan United States 6 1.9k 1.6× 379 1.1× 432 1.4× 136 0.9× 114 0.8× 8 2.3k
Danzhi Huang Switzerland 26 1.6k 1.3× 542 1.6× 150 0.5× 207 1.4× 61 0.5× 44 2.3k
Pieter F. W. Stouten United States 20 1.4k 1.2× 696 2.0× 306 1.0× 313 2.1× 166 1.2× 54 2.1k
Robert Fraczkiewicz United States 10 828 0.7× 160 0.5× 283 0.9× 110 0.7× 141 1.0× 16 1.3k
Alan C. Cheng United States 24 1.3k 1.1× 737 2.1× 259 0.8× 263 1.8× 80 0.6× 45 1.8k
Daniel K. Gehlhaar United States 17 1.5k 1.2× 725 2.1× 446 1.4× 318 2.1× 81 0.6× 24 2.0k
R.H.A. Folmer Sweden 21 1.2k 1.0× 292 0.8× 231 0.7× 132 0.9× 130 1.0× 28 1.6k

Countries citing papers authored by Ben Davis

Since Specialization
Citations

This map shows the geographic impact of Ben Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Davis more than expected).

Fields of papers citing papers by Ben Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Davis. The network helps show where Ben Davis may publish in the future.

Co-authorship network of co-authors of Ben Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Davis. A scholar is included among the top collaborators of Ben Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Davis. Ben Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lello, Paola Di, Ben Davis, Zoe Daniels, et al.. (2026). Targeting PTPN22 at Nonorthosteric Binding Sites─A Fragment Approach. ACS Omega. 11(2). 3465–3480.
2.
Fitzgerald, Edward A., Hanna F. Klein, David J. Hamilton, et al.. (2023). Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors. SLAS DISCOVERY. 29(1). 40–51. 12 indexed citations
3.
Blacksell, Stuart D., Ben Davis, Kathrin Summermatter, et al.. (2023). The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory— Shigella spp.. Applied Biosafety. 28(2). 96–101.
4.
Petri, László, Péter Ábrányi‐Balogh, Tı́mea Imre, et al.. (2022). A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors. European Journal of Medicinal Chemistry. 231. 114163–114163. 13 indexed citations
5.
Waudby, Christopher A., et al.. (2020). Two-dimensional NMR lineshape analysis of single, multiple, zero and double quantum correlation experiments. Journal of Biomolecular NMR. 74(1). 95–109. 11 indexed citations
6.
Erlanson, Daniel A., Ben Davis, & Wolfgang Jahnke. (2018). Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures. Cell chemical biology. 26(1). 9–15. 90 indexed citations
7.
Ruiz‐Carmona, Sergio, Peter Schmidtke, F. Javier Luque, et al.. (2016). Dynamic undocking and the quasi-bound state as tools for drug discovery. Nature Chemistry. 9(3). 201–206. 70 indexed citations
8.
Davis, Ben. (2013). Screening Protein–Small Molecule Interactions by NMR. Methods in molecular biology. 1008. 389–413. 11 indexed citations
9.
Potter, Andrew, Christophe Fromont, Stuart Ray, et al.. (2010). Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. Bioorganic & Medicinal Chemistry Letters. 20(22). 6483–6488. 69 indexed citations
10.
Potter, Andrew, Stuart Ray, Chris Bryant, et al.. (2009). Structure-guided design of α-amino acid-derived Pin1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(2). 586–590. 73 indexed citations
11.
Hubbard, Roderick E., Ben Davis, I‐Jen Chen, & Martin J. Drysdale. (2007). The SeeDs Approach: Integrating Fragments into Drug Discovery. Current Topics in Medicinal Chemistry. 7(16). 1568–1581. 57 indexed citations
12.
Davis, Ben, Mohammad Afshar, Gabriele Varani, et al.. (2004). Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic “Hot Spots”. Journal of Molecular Biology. 336(2). 343–356. 134 indexed citations
13.
Foloppe, Nicolas, et al.. (2004). A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Bioorganic & Medicinal Chemistry. 12(5). 935–947. 46 indexed citations
14.
Murchie, Alastair I.H., Ben Davis, Catherine Isel, et al.. (2003). Structure-based Drug Design Targeting an Inactive RNA Conformation: Exploiting the Flexibility of HIV-1 TAR RNA. Journal of Molecular Biology. 336(3). 625–638. 127 indexed citations
15.
Cary, Peter D., Christopher M. Read, Ben Davis, Paul C. Driscoll, & Colyn Crane‐Robinson. (2001). Solution structure and backbone dynamics of the DNA‐binding domain of mouse Sox‐5. Protein Science. 10(1). 83–98. 16 indexed citations
16.
Siegal, Gregg, Ben Davis, Søren M. Kristensen, et al.. (1998). Solution structure of the C-terminal SH2 domain of the p85α regulatory subunit of phosphoinositide 3-kinase 1 1Edited by P. E. Wright. Journal of Molecular Biology. 276(2). 461–478. 48 indexed citations
17.
McAlister, M., Ben Davis, Mark Pfuhl, & Paul C. Driscoll. (1998). NMR analysis of the N-terminal SRCR domain of human CD5: engineering of a glycoprotein for superior characteristics in NMR experiments. Protein Engineering Design and Selection. 11(10). 847–853. 16 indexed citations
18.
Pfuhl, Mark, et al.. (1998). Sequence specific 1H, 13C and15 N resonance assignment of rat CD2 domain 1. Journal of Biomolecular NMR. 12(3). 457–458. 3 indexed citations
19.
Neira, José L., Laura S. Itzhaki, Daniel E. Otzen, Ben Davis, & Alan R. Fersht. (1997). Hydrogen exchange in chymotrypsin inhibitor 2 probed by mutagenesis. Journal of Molecular Biology. 270(1). 99–110. 63 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Luque Breakdown of academic impact, for papers by Jayashree Srinivasan Breakdown of academic impact, for papers by Paul E. Morin Breakdown of academic impact, for papers by Andrew A. Bogan Breakdown of academic impact, for papers by Danzhi Huang Breakdown of academic impact, for papers by Pieter F. W. Stouten Breakdown of academic impact, for papers by Robert Fraczkiewicz Breakdown of academic impact, for papers by Alan C. Cheng Breakdown of academic impact, for papers by Daniel K. Gehlhaar Breakdown of academic impact, for papers by R.H.A. Folmer
Rankless by CCL
2026